SANTA CLARA, CA, Shape Memory Medical, a developer of custom shape memory polymers for endovascular markets, announced that it has completed $38 million in Series C financing.
Shape Memory Medical, a developer of custom shape memory polymers for endovascular markets, announced that it has completed $38 million in Series C financing led by Earlybird Venture Capital and with the participation of new and existing investors, including HBM Healthcare Investments (Cayman) Ltd., WexMed II LLC, HBM-Medfocus LLC, and Emergent Medical Partners II, L.P.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
